Inaccurate pretreatment staging can impact survival in early stage esophageal adenocarcinoma
Journal of Surgical Oncology2020Vol. 122(5), pp. 914–922
Citations Over TimeTop 15% of 2020 papers
Anthony J. Scholer, Abhineet Uppal, Shu‐Ching Chang, Debopriya Ghosh, Mary Garland Kledzik, Juan A. Santamaria‐Barria, Adam Khader, Ahmed Dehal, Trevan Fischer, Melanie Goldfarb
Abstract
Preoperative staging of esophageal adenocarcinoma has moderate reliability and accuracy for predicting pT and pN classification. Up to 25% of patients have discordant clinical and pathological staging, which impacts OS.
Related Papers
- → Modern 5-Year Survival of Resectable Esophageal Adenocarcinoma: Single Institution Experience with 263 Patients(2006)191 cited
- → Concordância entre os estadiamentos clínico e patológico em pacientes com câncer de pulmão não-pequenas células, estádios I e II, submetidos a tratamento cirúrgico(2007)6 cited
- → Concordance between Clinical and Pathological T and N Stages in Polish Patients with Head and Neck Cancers(2023)3 cited
- Evaluation on diagnosis and preoperative staging of 30 gastric cancer(2013)
- → Treatment of Early-Stage Esophageal Adenocarcinoma(2013)